LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
VJET
Catheter Precision, Inc.
There isn't enough reported data to score VJET yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
VJET Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
VJET's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
VJET PE Valuation
VJET has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
VJET Forward outlook
There aren't enough analyst estimates for VJET to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the stronger earnings trend. Trailing diluted EPS is up 51% for LLY versus VJET down 159%.
VJET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$64,805.04 | +$44,178.96 |
| Q2 2023 | -$72,567.99 | +$91,782.01 |
| Q1 2023 | -$96,841.84 | +$164,408.16 |
| Q4 2022 | -$98,705.00 | +$372,495.00 |
| Q3 2020 | -$4,346,250.00 | +$7,528,750.00 |
VJET is still losing money, but far less than before: $64,805.04 per share over the past year, against $11,875,000.00 at its worst in late 2019.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over VJET on profitability, with a higher operating margin.
VJET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1M | +381% |
| Q1 2026 | $432K | +202% |
| Q4 2025 | $238K | +60% |
| Q3 2025 | $226K | +135% |
| Q2 2025 | $212K | +128% |
| Q1 2025 | $143K | +74% |
| Q4 2024 | $149K | +16% |
| Q3 2024 | $96K | -28% |
VJET's revenue is recovering but still below its 2019 peak: $1M last quarter, up 381% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -388% | +1822 points |
| Q1 2026 | -537% | +1963 points |
| Q4 2025 | -4143% | -2096 points |
| Q3 2025 | -1337% | +1641 points |
| Q2 2025 | -2210% | +711 points |
| Q1 2025 | -2500% | +690 points |
| Q4 2024 | -2048% | -19 points |
| Q3 2024 | -2978% | -926 points |
VJET's operating margin was −388% last quarter, up 1822 points from the same quarter a year ago, near the top of its range since 2019.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over VJET on cash generation, producing positive trailing cash flow while its opponent burns cash.
VJET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.9M | -$606K |
| Q1 2026 | -$2.8M | -$454K |
| Q4 2025 | -$1.5M | +$1.4M |
| Q3 2025 | -$2.2M | +$585K |
| Q2 2025 | -$2.3M | -$528K |
| Q1 2025 | -$2.3M | -$384K |
| Q4 2024 | -$2.9M | -$957K |
| Q3 2024 | -$2.8M | -$937K |
VJET has burned cash in almost every quarter: −$9M over the past year, against −$10M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over VJET on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
VJET Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +31% | +1.2K shares |
| 1 year | +41% | +1.5K shares |
| 3 years | +86633% | +5.2K shares |
VJET has 5,204 diluted shares, up 41% from a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
VJET Net Leverage
VJET's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
VJET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.4 | Oversold |
| Stochastic | 0.7 | Oversold |
VJET's weekly RSI is 27 (oversold) and its Stochastic is 1 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
VJET PE vs Healthcare Sector
VJET has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over VJET on trend strength, trading above more of its moving averages.
VJET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.92 | 42% below |
| 20 week MA | $2.45 | 78% below |
| 50 week MA | $9.55 | 94% below |
| 100 week MA | $29.5 | 98% below |
| 200 week MA | $689.2 | 100% below |
VJET is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over VJET on returns for 2026, with the stronger performance.
VJET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2,113,750.0 | $681,150.0 | -68% |
| 2021 | $681,150.0 | $164,350.0 | -76% |
| 2022 | $164,350.0 | $8,246.0 | -95% |
| 2023 | $8,246.0 | $767.6 | -91% |
| 2024 | $767.6 | $77.3 | -90% |
| 2025 | $77.3 | $16.8 | -78% |
| 2026 YTD | $16.8 | $0.53 | -97% |
VJET has finished every year since 2020 lower, and it's down 97% so far in 2026.